Carfilzomib significantly improves the progression-free survival of high-risk patients in multiple myeloma.
scientific article published on 20 July 2016
Author/s
author: Herve Avet-Loiseau, Athanasios Dimopoulos, Ivan Špička, Tamás Masszi, Roman Hajek, Albert Oriol, Ruben Niesvizky, Antonio Palumbo, Philippe Moreau, Vesselina Goranova-Marinova, Mihaela Obreja, María Victoria Mateos, Jiri Minarik, Vishal Kukreti, Andrzej Jakubowiak, Laura Rosiñol, Michael Wang
Work details
Copyright status
Copyright status information is not available for this work. The copyright status depends on the jurisdiction, the author's date of death and the date the work was created or published.
To learn more about copyright terms in different countries, visit the countries and terms page.